Emergent Expanded Access for ahSC Augmentation of Nerve Autografts After Severe Peripheral Nerve Injury.
| Status: | Temporarily not available |
|---|---|
| Conditions: | Hospital |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 3/7/2019 |
Emergent Expanded Access to Use Autologous Human Schwann Cell Augmentation of Nerve Autograft Repair in a Single Patient With Severe Peripheral Nerve Injury
The primary purpose of this research study is to determine the safety of injecting ones own
Schwann cells to augment sural nerve autografts after a severe, non-lacerating injury to the
sciatic nerve has occurred.
Schwann cells to augment sural nerve autografts after a severe, non-lacerating injury to the
sciatic nerve has occurred.
The secondary purpose of this research project is to evaluate whether transplanted Schwann
cells can enhance recovery of sensory and motor function. Emergency expanded access for a
single patient was granted, as the patient was an ideal candidate for sural nerve repair
augmented by autologous Schwann cells which could be harvested from a relatively small
segment of sensory nerve. The cells were expanded using cell culture techniques and placed
along with the sural nerve grafts wrapped by an FDA approved collagen matrix (Duragen). This
study is being conducted at the Jackson Memorial and the University of Miami health systems.
As a research subject the patient will be in this study for a total of 5 years from the date
receiving Schwann cell transplant augmentation of sural nerve autografts.
cells can enhance recovery of sensory and motor function. Emergency expanded access for a
single patient was granted, as the patient was an ideal candidate for sural nerve repair
augmented by autologous Schwann cells which could be harvested from a relatively small
segment of sensory nerve. The cells were expanded using cell culture techniques and placed
along with the sural nerve grafts wrapped by an FDA approved collagen matrix (Duragen). This
study is being conducted at the Jackson Memorial and the University of Miami health systems.
As a research subject the patient will be in this study for a total of 5 years from the date
receiving Schwann cell transplant augmentation of sural nerve autografts.
Single patient with severe sciatic nerve injury enrolled under emergency request
We found this trial at
1
site
University of Miami A private research university with more than 15,000 students from around the...
Click here to add this to my saved trials
